MTOR and urinary bladder cancer: In bladder cancer treatment, TET induced autophagy in human bladder cancer cells by regulating AMPK/mTOR signaling, which favors apoptosis induction, suggesting that it may be a potential anticancer candidate for the treatment of bladder cancer [155].